Patent ID: 11931407
Assignee: EMERGEX VACCINES HOLDING LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 11:
12. A vaccine composition comprising
(a) a polynucleotide that encodes a flavivirus peptide comprising one or both of the CD8+ T cell epitopes set out in SEQ ID NOs: 9 and 10, wherein the flavivirus peptide is about 8 to about 20 amino acids in length, or
(b) the full complement of a polynucleotide that encodes a flavivirus peptide comprising one or both of the CD8+ T cell epitopes set out in SEQ ID NOs: 9 and 10, wherein the flavivirus peptide is about 8 to about 20 amino acids in length.